drugset

drugset / Trial / NCT00449423

Metabolic Modulation as Treatment in Acute Heart Failure

NCT00449423 ↗

Phase 2 Terminated 32 enrolled University of Aarhus

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to evaluate whether metabolic modulation improves hemodynamics and outcome in acute heart failure

Timeline

Start: 2007-03
Primary completion: —
Completion: 2007-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Acipimox	Small molecule	—	—

Indications